Looking within the zebrafish to understand the tuberculous granuloma

Advances in Experimental Medicine and Biology

Volumn 783, Issue , 2013, Pages 251-266

  Ramakrishnan, Lalita ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; Cell death; Host matrix metalloproteinase 9 (MMP9); Macrophages; Mycobacteria; Mycobacterium bovis bacillus Calmette Gu rin (BCG) vaccine strain; Mycobacterium marinum; Mycobacterium Tuberculosis; Necrosis; Neutrophils; Tubercles; Tuburculous granuloma; Tumor necrosis factor; Zebrafish

Indexed keywords

CD4 ANTIGEN; GELATINASE B; MYELOID DIFFERENTIATION FACTOR 88; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ZEBRAFISH PROTEIN;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSMISSION; CD4+ T LYMPHOCYTE; CELL DEATH; CELL MATURATION; GRANULOMA; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; MACROPHAGE; MOLECULAR MECHANICS; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TUBERCULOSIS; ZEBRA FISH; ANIMAL; ANIMAL DISEASE; ATYPICAL MYCOBACTERIOSIS; DISEASE MODEL; DISEASE RESISTANCE; ENZYME INDUCTION; GROWTH, DEVELOPMENT AND AGING; IMMUNE EVASION; IMMUNOLOGY; LARVA; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; REVIEW; TUBERCULOMA; VIRULENCE;

ANIMALS; ANTIGENS, BACTERIAL; APOPTOSIS; BACTERIAL PROTEINS; BCG VACCINE; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; ENZYME INDUCTION; HUMANS; IMMUNE EVASION; LARVA; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; TUBERCULOMA; VIRULENCE; ZEBRAFISH; ZEBRAFISH PROTEINS;

MLCS; MLOWN;

EID: 84879935517     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6111-1_13     Document Type: Article

References (123)

1. Boros DL (ed) (2003) Granulomatous infections and inflammations cellular and molecular mechanisms. ASM Press, Washington, DC
2. Adams DO (1976) The granulomatous inflammatory response: a review. Am J Pathol 84:164-192
3. Spector WG (1969) The granulomatous inflammatory exudate. Int Rev Exp Pathol 8:1-55
4. Williams GT, Williams WJ (1983) Granulomatous inflammationa review. J Clin Pathol 36:723-733
5. Adams DO (1974) The structure of mononuclear phagocytes differentiating in vivo I Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG). Am J Pathol 76:17-48
6. Cohn ZA (1968) The structure and function of monocytes and macrophages. Adv Immunol 9:163-214
7. Dannenberg AM Jr (1968) Cellular hypersensitivity and cellular immunity in the pathogensis of Tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes. Bacteriol Rev 32:85-102
8. Bouley DM et al (2001) Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect Immun 69:7820-7831
9. Canetti G (1955) The tubercle bacillus in the pulmonary lesion of man; histobacteriology and its bearing on the therapy of pulmonary Tuberculosis, American Rev edn. Springer Publishing Company, New York, p 226
10. Hunter RL (2011) Pathology of post primary Tuberculosis of the lung: an illustrated critical review. Tuberculosis 91:497-509
11. Kumar V, Abbas AK, Fausto N (2005) Robbins and Cotran pathological basis of disease, 7th edn. Elsevier Saunders, Philadelphia
12. Rich AR (1946) The pathogenesis of Tuberculosis, 2nd edn. Charles C Thomas, Springfield
13. Ramakrishnan L (2012) Revisiting the role of the granuloma in Tuberculosis. Nat Rev Immunol 12:352-366
14. Dannenberg AMJ (1993) Immunopathogenesis of pulmonary Tuberculosis. Hosp Pract 28:51-58
15. Wolf AJ et al (2007) Mycobacterium Tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 179:2509-2519
16. Cosma CL, Sherman DR, Ramakrishnan L (2003) The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 57:641-676
17. Feldman WH, Baggenstoss AH (1938) The reisdual infectivity of the primary complex of Tuberculosis. Am J Pathol 14:473-490
18. Opie EL, Aronson JD (1927) Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med 4:1-21
19. Flynn JL, Chan J (2001) Immunology of Tuberculosis. Annu Rev Immunol 19:93-129
20. Kaufmann SH (2000) Is the development of a new Tuberculosis vaccine possible? Nat Med 6:955-960
21. Lawn SD, Butera ST, Shinnick TM (2002) Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium Tuberculosis. Microbes Infect 4:635-646
22. North RJ, Izzo AA (1993) Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ. Am J Pathol 142:1959-1966
23. Cooper AM et al (1993) Disseminated Tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178:2243-2247
24. Cooper AM et al (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium Tuberculosis. J Exp Med 186:39-45
25. Flynn JL et al (1993) An essential role for interferon gamma in resistance to Mycobacterium Tuberculosis infection. J Exp Med 178:2249-2254
26. Fremond CM et al (2007) IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium Tuberculosis infection. J Immunol 179:1178-1189
27. Fremond CM et al (2004) Fatal Mycobacterium Tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest 114:1790-1799
28. Juffermans N et al (2000) Interleukin-1 signaling is essential for host defense during murine pulmonary Tuberculosis. J Infect Dis 182:902-908
29. Scanga CA et al (2004) MyD88-deficient mice display a profound loss in resistance to Mycobacterium Tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun 72:2400-2404
30. Sugawara I, Yamada H, Mizuno S (2003) Relative importance of STAT4 in murine Tuberculosis. J Med Microbiol 52:29-34
31. Algood HM, Lin L, Flynn JL (2005) Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in Tuberculosis. Clin Infect Dis 41:S189-S193
32. Bean AG et al (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium Tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162:3504-3511
33. Chakravarty SD et al (2008) Tumor necrosis factor blockade in chronic murine Tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect Immun 76:916-926
34. Flynn JL et al (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium Tuberculosis in mice. Immunity 2:561-572
35. Kindler V et al (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740
36. Roach DR et al (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620-4627
37. Stenger S (2005) Immunological control of Tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis 64:iv24-iv28
38. Clay H, Volkman HE, Ramakrishnan L (2008) Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29:283-294
39. Rubin EJ (2009) The granuloma in Tuberculosis-friend or foe? N Engl J Med 360:2471-2473
40. Bold TD, Ernst JD (2009) Who benefits from granulomas, mycobacteria or host? Cell 136:17-19
41. Ulrichs T, Kaufmann SH (2006) New insights into the function of granulomas in human Tuberculosis. J Pathol 208:261-269
42. Murphy K, Travers P, Walport M (2008) Janeway's immunobiology, 7th edn. Garland Science Taylor and Francis Group, New York
43. Mandell GL, Bennett JE, Dolin R (eds) (2010) Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th edn. Churchill Livingston, Philadelphia
44. Schaff H, Zumla A (eds) (2009) Tuberculosis. Elsevier Saunders, Philadelphia
45. Longo DL et al (eds) (2012) Harrison's principles of internal medicine. McGraw-Hill, New York
46. Tobin DM, Ramakrishnan L (2008) Comparative pathogenesis of Mycobacterium marinum and Mycobacterium Tuberculosis. Cell Microbiol 10:1027-1039
47. Ramakrishnan L (1997) Images in clinical medicine Mycobacterium marinum infection of the hand. N Engl J Med 337:612
48. Ramakrishnan L et al (1997) Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens). Infect Immun 65:767-773
49. Swaim LE et al (2006) Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous Tuberculosis and is moderated by adaptive immunity. Infect Immun 74:6108-6117
50. Tobin DM et al (2012) Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148:434-446
51. Tobin DM et al (2010) The lta4 h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140:717-730
52. Saunders BM et al (2002) CD4 is required for the development of a protective granulomatous response to pulmonary Tuberculosis. Cell Immunol 216:65-72
53. van Rie A et al (1999) Exogenous reinfection as a cause of recurrent Tuberculosis after curative treatment. N Engl J Med 341:1174-1179
54. Verver S et al (2005) Rate of reinfection Tuberculosis after successful treatment is higher than rate of new Tuberculosis. Am J Respir Crit Care Med 171:1430-1435
55. Caminero JA et al (2001) Exogenous reinfection with Tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med 163:717-720
56. Kaufmann SH (2001) How can immunology contribute to the control of Tuberculosis? Nat Rev Immunol 1:20-30
57. Balasubramanian V et al (1994) Pathogenesis of Tuberculosis: pathway to apical localization. Tuber Lung Dis 75:168-178
58. Hernandez-Pando R et al (2000) Persistence of DNA from Mycobacterium Tuberculosis in superficially normal lung tissue during latent infection. Lancet 356:2133-2138
59. McMurray DN (2003) Hematogenous reseeding of the lung in low-dose, aerosol-infected guinea pigs: unique features of the host-pathogen interface in secondary tubercles. Tuberculosis 83:131-134
60. Grosset J (2003) Mycobacterium Tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob Agents Chemother 47:833-836
61. Cosma CL, Humbert O, Ramakrishnan L (2004) Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 5:828-835
62. Cosma CL et al (2008) Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci. J Infect Dis 198:1851-1855
63. Chan K et al (2002) Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection. Proc Natl Acad Sci U S A 99:3920-3925
64. Ramakrishnan L, Federspiel NA, Falkow S (2000) Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE- PGRS family. Science 288:1436-1439
65. Cooper AM (2009) Cell-mediated immune responses in Tuberculosis. Annu Rev Immunol 27:393-422
66. Gallegos AM, Pamer EG, Glickman MS (2008) Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M Tuberculosis infection. J Exp Med 205:2359-2368
67. Gill W et al (2009) A replication clock for Mycobacterium Tuberculosis. Nature Med 15:211-214
68. Wolf AJ et al (2008) Initiation of the adaptive immune response to Mycobacterium Tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 205:105-115
69. North RJ, Jung YJ (2004) Immunity to Tuberculosis. Annu Rev Immunol 22:599-623
70. Andersen P (1997) Host responses and antigens involved in protective immunity to Mycobacterium Tuberculosis. Scand J Immunol 45:115-131
71. Saunders BM, Cooper AM (2000) Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 78:334-341
72. Davis JM et al (2002) Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17:693-702
73. Volkman HE et al (2004) Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol 2:e367
74. Davis JM, Ramakrishnan L (2009) The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136:37-49
75. Egen JG et al (2008) Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28:271-284
76. Egen JG et al (2011) Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34:807-819
77. Sherman DR et al (2004) Mycobacterium Tuberculosis H37Rv: Delta RD1 is more virulent than M bovis bacille Calmette-Guerin in long-term murine infection. J Infect Dis 190:123-126
78. Gao LY et al (2004) A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol Microbiol 53:1677-1693
79. Guinn KM et al (2004) Individual RD1-region genes are required for export of ESAT-6/ CFP-10 and for virulence of Mycobacterium Tuberculosis. Mol Microbiol 51:359-370
80. Choi HH et al (2010) Endoplasmic reticulum stress response is involved in Mycobacterium Tuberculosis protein ESAT-6-mediated apoptosis. FEBS Lett 584:2445-2454
81. Derrick SC, Morris SL (2007) The ESAT-6 protein of Mycobacterium Tuberculosis induces apoptosis of macrophages by activating caspase expression. Cell Microbiol 9:1547-1555
82. Mishra BB et al (2010) Mycobacterium Tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 12:1046-1063
83. Behar SM et al (2011) Apoptosis is an innate defense function of macrophages against Mycobacterium Tuberculosis. Mucosal Immunol 4:279-287
84. Fratazzi C et al (1997) Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol 158:4320-4327
85. Gan H et al (2008) Mycobacterium Tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol 9:1189-1197
86. Keane J, Shurtleff B, Kornfeld H (2002) TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium Tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis 82:55-61
87. Martin CJ et al (2012) Efferocytosis is an innate antibacterial mechanism. Cell Host and Microbe 12:289-300
88. Oddo M et al (1998) Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium Tuberculosis. J Immunol 160:5448-5454
89. Molloy A (1994) Laochumroonvorapong, and G Kaplan, Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J Exp Med 180:1499-1509
90. Lammas DA et al (1997) ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7:433-444
91. Armstrong JA, Hart D (1975) Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 142:1-16
92. van der Wel N et al (2007) M Tuberculosis and M leprae translocate from the phagolysosome to the cytosol in myeloid cells Cell 129:1287-1298
93. Briken V, Miller JL (2008) Living on the edge: inhibition of host cell apoptosis by Mycobacterium Tuberculosis. Futur Microbiol 3:415-422
94. Hinchey J et al (2007) Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium Tuberculosis. J Clin Invest 117:2279-2288
95. Jayakumar D, Jacobs WR Jr, Narayanan S (2008) Protein kinase E of Mycobacterium Tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection. Cell Microbiol 10:365-374
96. Velmurugan K et al (2007) Mycobacterium Tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog 3:e110
97. Yang CT et al (2012) Neutrophils protect against Tuberculosis by oxidative killing of mycobacteria phagocytosed from granuloma macrophages. Cell Host Microbe 12:301-312
98. Cree IA et al (1987) Cell death in granulomata: the role of apoptosis. J Clin Pathol 40:1314-1319
99. Keane J et al (1997) Infection by Mycobacterium Tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 65:298-304
100. Fayyazi A et al (2000) Apoptosis of macrophages and T cells in Tuberculosis associated caseous necrosis. J Pathol 191:417-425
101. Clay H et al (2007) Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2:29-39
102. Chen M et al (2008) Lipid mediators in innate immunity against Tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med 205:2791-2801
103. Divangahi M et al (2009) Mycobacterium Tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 10:899-906
104. Divangahi M et al (2010) Eicosanoid pathways regulate adaptive immunity to Mycobacterium Tuberculosis. Nat Immunol 11:751-758
105. Volkman HE et al (2010) Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327:466-469
106. Van den Steen E et al (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37:375-536
107. Banaiee N et al (2006) Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium Tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 176:3019-3027
108. Fortune SM et al (2004) Mycobacterium Tuberculosis inhibits macrophage responses to IFNgamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol 172:6272-6280
109. Kincaid EZ, Ernst JD (2003) Mycobacterium Tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-gamma without inhibiting STAT1 function. J Immunol 171:2042-2049
110. Ting LM et al (1999) Mycobacterium Tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol 163:3898-3906
111. Stockhammer OW et al (2009) Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection. J Immunol 182:5641-5653
112. Taylor JL et al (2006) Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium Tuberculosis infection. Infect Immun 74:6135-6144
113. Park KJ et al (2005) Expression of matrix metalloproteinase-9 in pleural effusions of Tuberculosis and lung cancer. Respiration 72:166-175
114. Price NM et al (2001) Identification of a matrix-degrading phenotype in human Tuberculosis in vitro and in vivo. J Immunol 166:4223-4230
115. Sheen P et al (2009) High MMP-9 activity characterises pleural Tuberculosis correlating with granuloma formation. Eur Respir J 33:134-141
116. Elkington T et al (2007) Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in Tuberculosis. Am J Respir Cell Mol Biol
117. Adams KN et al (2011) Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39-53
118. Chackerian AA et al (2002) Dissemination of Mycobacterium Tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 70:4501-4509
119. Schreiber HA et al (2011) Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 121:3902-3913
120. Akira M, Sakatani M, Ishikawa H (2000) Transient radiographic progression during initial treatment of pulmonary Tuberculosis: CT findings. J Comput Assist Tomogr 24:426-431
121. Bobrowitz ID (1980) Reversible roentgenographic progression in the initial treatment of pulmonary Tuberculosis. Am Rev Respir Dis 121:735-742
122. Russell DG (2007) Who puts the tubercle in Tuberculosis? Nat Rev Microbiol 5:39-47
123. Takaki K et al (2012) An in vivo platform for rapid high-throughput antitubercular drug discovery. Cell Rep 2:175-184